Upstream Bio (UPB) Accumulated Depreciation (2023 - 2026)

Upstream Bio's Accumulated Depreciation history runs 4 years deep, the most recent figure standing at $393000.0 for Q1 2026.

• In Q1 2026, Accumulated Depreciation rose 97.49% year-over-year to $393000.0; the TTM figure through Mar 2026 stood at $393000.0 (up 97.49% YoY), while the FY2025 annual figure was $344000.0, up 120.51% from the prior year.
• Accumulated Depreciation for Q1 2026 stood at $393000.0, up from $344000.0 in the prior quarter.
• The five-year high for Accumulated Depreciation was $393000.0 in Q1 2026, with the low at $67000.0 in Q4 2023.
• The 4-year median for Accumulated Depreciation is $220000.0 (2025), against an average of $224250.0.
• The sharpest annual moves came in 2025 and 2026: Accumulated Depreciation soared 168.22% in 2025, then jumped 97.49% in 2026.
• Upstream Bio's Accumulated Depreciation stood at $67000.0 in 2023, then jumped by 132.84% to $156000.0 in 2024, then jumped by 120.51% to $344000.0 in 2025, then advanced by 14.24% to $393000.0 in 2026.
• Business Quant data shows UPB's Accumulated Depreciation at $393000.0 in Q1 2026, $344000.0 in Q4 2025, and $287000.0 in Q3 2025.